ESLAW icon

Estrella Immunopharma, Inc. Warrant
ESLAW

Overview Fund Activity

7 hedge funds and large institutions have $4.52M invested in Estrella Immunopharma, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BFM
1
Boothbay Fund Management
New York
$1.93M
2
ASM
2
ATW SPAC Management
New York
$1.93M
3
RCM
3
Radcliffe Capital Management
Pennsylvania
$495K
4
KPF
4
K2 Principal Fund
Ontario, Canada
$59K
5
CH
5
CVI Holdings
Delaware
$36K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
ASM
1
ATW SPAC Management
New York
$1.93M 195,000 +195,000 New
BFM
2
Boothbay Fund Management
New York
$1.93M 195,000 +195,000 New
RCM
3
Radcliffe Capital Management
Pennsylvania
$495K 50,000 +50,000 New
KPF
4
K2 Principal Fund
Ontario, Canada
$59K 143,947 +143,947 New
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$36K 87,500 +87,500 New
CH
6
CVI Holdings
Delaware
$36K 87,500 +87,500 New
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$34K 82,500 +82,500 New
CFGS
8
Concourse Financial Group Securities
Alabama
– – – –